首页> 外文期刊>Traditional medicine research. >Challenges and opportunities of applying P4 medicine and traditional Chinese medicine for cancer treatment and prevention in the 21st century: A medical oncologist’s perspectives
【24h】

Challenges and opportunities of applying P4 medicine and traditional Chinese medicine for cancer treatment and prevention in the 21st century: A medical oncologist’s perspectives

机译:肿瘤学家对21世纪将P4药物和中药应用于癌症治疗和预防的挑战与机遇

获取原文
       

摘要

Being one of the deadliest diseases, cancer needs a stronger dose of P4 medicine (Predictive, Preventive, Personalized and Participatory) first proposed by Dr. Hood and TCM intervention, as cancer treatment still largely relies on the decade-old cytotoxic chemotherapy, radiation and surgery. This overview uses colorectal cancer model to discuss pitfalls in current cancer prevention and treatment strategies, which saw many randomized phase III studies failing to meet the study primary endpoints or marginally meeting the study objectives. Complete sequencing of whole human genome provided much of the hopes as well as hypes for precision medicine, as genomic diversity, ever changing tumor mutation landscape, SNP and complex microRNA regulation from the intron region and epigenetics make genotype to phenotype correlation study increasingly challenging. As a participant of One hundred Persons Pioneers Project, I witnessed first hand how a comprehensive scientific wellness study that integrates whole genomics, microbiome, and metabolome nutrition along with comprehensive laboratory examinations can be used to diagnose pre-illness in all “healthy” participants. Pre-illness can be best intervened by none pharmaceutical means and traditional Chinese Medicine (TCM) adept in restoring internal healing mechanisms, opening up the blocked network and balancing the five-elements homeostasis. Following TCM principles, we were able to design a therapy that effectively targets colon cancer stem cells and its microenvironment leading to more doubling of overall survival with reduction in overall toxicities. Pre-illness diagnosis, cancer immunotherapy, TCM medicine is about restoring internal healing power by letting go brakes on “good” immune systems to go after the “bad” cancer cells. Time is ripe to integrate our knowledge in genomics immune systems, stem cell biology, nutrition, inflammation, metabolism, systems medicine, and modern TCM to deliver a level of care that most of major illness including cancer are now minor pre-illness and are delayed, prevented, or cured at their earliest stages along with elevation in healthy index in the individual, their families and society as a whole globally. Keywords P4 Medicine, Traditional Chinese medicine, Cancer treatment, Cancer prevention.
机译:作为最致命的疾病之一,癌症需要更大剂量的P4药物(预测性,预防性,个性化和参与性),这是Hood博士和TCM干预首先提出的,因为癌症的治疗仍主要依赖已有十年历史的细胞毒性化学疗法,放射线和手术。本概述使用结直肠癌模型来讨论当前癌症预防和治疗策略中的陷阱,该研究发现许多随机的III期研究未能达到研究的主要终点或仅达到研究目标的水平。整个人类基因组的完整测序为精密医学提供了许多希望和炒作,因为基因组多样性,不断变化的肿瘤突变格局,内含子区域和表观遗传学的SNP和复杂的microRNA调控使基因型到表型相关性研究越来越具有挑战性。作为“一百人先锋计划”的参与者,我亲眼目睹了如何将整合了整个基因组学,微生物组和代谢组营养与全面的实验室检查相结合的全面科学健康研究,用于诊断所有“健康”参与者的病前状况。最好不要采用任何药物干预手段来预防病前疾病,而擅长恢复内部愈合机制,开放受阻网络并平衡五要素稳态的中药(TCM)则可以最好地干预。遵循中医原则,我们能够设计出一种有效靶向结肠癌干细胞及其微环境的疗法,从而使总体存活率提高一倍,同时降低总体毒性。疾病前诊断,癌症免疫疗法,中医医学旨在通过放开对“不良”癌细胞的“良好”免疫系统的制动来恢复内部治愈能力。将我们的知识整合到基因组免疫系统,干细胞生物学,营养,炎症,新陈代谢,系统医学和现代中医等方面的时机已经成熟,以提供一定水平的护理,包括癌症在内的大多数主要疾病现在都属于轻度疾病,并且会延迟,预防或治愈,以及个人,家庭和整个社会的健康指数提高。关键词P4医学;中药;癌症治疗;癌症预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号